...
首页> 外文期刊>Oncology letters >miRNA regulation of Sirtuin-1 expression in human astrocytoma
【24h】

miRNA regulation of Sirtuin-1 expression in human astrocytoma

机译:人星形细胞瘤中Sirtuin-1表达的miRNA调控

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Sirtuins are a family of 7 histone deacetylases largely involved in the regulation of cell proliferation, survival and death. The role of sirtuins in tumorigenesis and cancer progression has been previously studied in certain cancer types. Few studies have investigated sirtuin expression in gliomas, with controversial results. The aim of the present study was to investigate the expression of sirtuin-1 (Sirt-1) in diffuse astrocytoma [low grade astrocytoma (LGA)], anaplastic astrocytoma (AA) and glioblastoma multiforme (GBM) and in primary glioma cell lines: PLGAC (primary LGA cells); PAAC (primary AA cells); and PGBMC (primary GBM cells). Tumor samples were obtained from patients who underwent craniotomy for microsurgical tumor resection at the Neurosurgery Unit of the University of Messina between 2011 and 2014. Sirt-1 expression was qualitatively analyzed in 30 human glial tumor samples and 5 non-neoplastic brain tissue (NBT) specimens using immunohistochemistry and western blotting techniques. Sirt-1 expression was quantitatively analyzed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). In addition, Sirt-1 expression in primary cell lines was investigated by immunoblotting and RT-qPCR. Sirt-1 expression was downregulated in gliomas compared to NBTs. Sirt-1 levels also varied among different tumor grades, with more evident downregulation in high-grade (P<0.001) than low-grade tumors (P<0.01). These data were confirmed in cell lines, with the exception of upregulation of protein level in the highest malignancy grade cell lines. The present results suggest a role for miRNA-34a, miRNA-132 and miRNA-217 in the epigenetic control of Sirt-1 during gliomagenesis and progression, and demonstrate the different implications of Sirt-1 in human tissues and cell lines. Furthermore, the present results reveal that Sirt-1 may be an intrinsic regulator of tumor progression and the regulation of Sirt-1 involves complex molecular pathways. However, the biological functions of Sirt-1 in gliomagenesis require additional investigation.
机译:Sirtuins是7个组蛋白脱乙酰基酶家族,主要参与细胞增殖,存活和死亡的调节。沉默调节蛋白在肿瘤发生和癌症进展中的作用先前已经在某些癌症类型中进行了研究。很少有研究对神经胶质瘤中sirtuin的表达进行研究,但结果存在争议。本研究的目的是研究sirtuin-1(Sirt-1)在弥漫性星形细胞瘤[低度星形细胞瘤(LGA)],间变性星形细胞瘤(AA)和多形性胶质母细胞瘤(GBM)中以及在原代神经胶质瘤细胞系中的表达: PLGAC(原代LGA细胞); PAAC(原AA细胞);和PGBMC(主要GBM单元)。从2011年至2014年在墨西拿大学神经外科的颅骨切开术患者中获取肿瘤样品。定性分析了30例人类神经胶质瘤样品和5例非肿瘤性脑组织(NBT)中Sirt-1的表达。使用免疫组织化学和蛋白质印迹技术的标本。通过逆转录定量聚合酶链反应(RT-qPCR)定量分析Sirt-1表达。另外,通过免疫印迹和RT-qPCR研究了Sirt-1在原代细胞系中的表达。与NBT相比,在神经胶质瘤中Sirt-1表达下调。 Sirt-1水平在不同肿瘤级别之间也有所不同,在高级别肿瘤中(P <0.001)明显低于低级别肿瘤(P <0.01)。这些数据在细胞系中得到证实,但最高恶性等级细胞系中蛋白质水平的上调除外。目前的结果表明,miRNA-34a,miRNA-132和miRNA-217在神经胶质瘤发生和发展过程中对Sirt-1的表观遗传控制中起着作用,并证明了Sirt-1在人体组织和细胞系中的不同含义。此外,目前的结果表明,Sirt-1可能是肿瘤进展的内在调节剂,而Sirt-1的调节涉及复杂的分子途径。但是,Sirt-1在神经胶质瘤发生中的生物学功能需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号